Research. Advocacy. Support.

We advance ovarian cancer research while supporting women and their families.

Learn more about OCRFA

September is Ovarian Cancer Awareness Month

There is power in the ovarian cancer community. OCRFA's President & CEO Audra Moran talks about what's ahead this September.

Donate Today

Know Your Risks

About 20 to 25 percent of women diagnosed with ovarian cancer have a hereditary tendency to develop the disease.

Learn about your risks

Risk Factors

Many factors can increase or decrease a woman's risk of developing ovarian cancer.

Increases Risk

  • Family history of breast, ovarian or colon cancer
  • Genetic mutations like BRCA
  • Post-menopausal
  • Increased age

Decreases Risk

  • Pregnancy
  • Breastfeeding
  • Use of oral contraceptives

Know the Symptoms

  • Bloating
  • Difficulty Eating
  • Pelvic / Abdominal Pain
  • Urinary Frequency

If these symptoms occur for more than 2 weeks and these symptoms are new or unusual for you, see a gynecologist and ask about ovarian cancer. Research shows that seeing a gynecologic oncologist for surgery and treatment significantly improves outcomes.

2017 Ovarian Cancer National Conference

OCRFA’s Ovarian Cancer National Conference brought together hundreds of survivors and caregivers for a weekend filled with expert presentations, newfound friendships, and hope for the future.

Learn more

Latest News

  • Studies Show that Current Chemotherapy Dosage is Still Best Option for Epithelial Ovarian Cancer

    (September 15, 2017) Two studies just confirmed that, depending on one’s genetic background, the standard treatment for epithelial ovarian cancer is most likely the best option. The studies, conducted with two different populations, showed that, although the outcomes conflicted one another, the option that offered the best progression free survival was the one already used.… More

  • The Link Between Chemotherapy Resistance and a Tumor’s BRCA1/2 Mutations

    (September 5, 2017) Researchers at the University of Pennsylvania recently uncovered a link between one’s resistance to common types of chemotherapy and one’s tumor BRCA1/2 mutation status. More specifically, they looked at both copies of the BRCA genes, one copy given by each parent. Until recently, it had been assumed that mutated BRCA gene left… More

  • Share Your #OvarianStory to Raise Awareness

    Every 23 minutes another woman is diagnosed with ovarian cancer. All of them have a story. This September, we’re inviting you to share your #OvarianStory. Help raise awareness of ovarian cancer, from the first often-missed symptoms, to diagnosis and beyond. By speaking out, you can help other women and you can shine a spotlight on… More


Upcoming Events